文献速递慢性静脉疾病静脉血栓栓塞

有深静脉血栓史患者行腔内热消融的安全性与有效性

Safety and efficacy of endovenous ablation in patients with a history of deep vein thrombosis.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2024-04-25

基于美国血管质量倡议静脉曲张注册数据库2014年1月至2021年7月33,892例次腔内热消融,比较有深静脉血栓史(1698例,7.2%)与无史患者。有史者新发深静脉血栓(1.4% vs 0.8%,P=.03)、近端血栓延伸(2.3% vs 1.6%,P=.045)及出血(0.2% vs 0.04%,P=.03)风险更高,但技术失败率无显著差异,远期再通风险增加(HR 1.90,95%CI 1.46-2.46,P<.001)。

要点

  • 有深静脉血栓史者术后新发深静脉血栓风险升高(1.4% vs 0.8%,P=.03)。
  • 有史者近端血栓延伸风险升高(2.3% vs 1.6%,P=.045),EHIT II-IV无差异。
  • 有史者远期再通风险增加(HR 1.90,95%CI 1.46-2.46,P<.001)。

核心结论

  • 有深静脉血栓史患者行腔内热消融有效,但需告知深静脉血栓风险虽低但仍升高。
  • 术前是否继续抗凝应个体化决策。

研究设计与样本

  • 回顾性队列研究,查询美国国家血管质量倡议静脉曲张注册数据库2014年1月至2021年7月数据。
  • 共33,892例次腔内热消融,涉及23,572例患者,年龄13至90岁;1698例(7.2%)有深静脉血栓史。
  • 比较有与无深静脉血栓史患者接受射频或激光消融的结局。

主要发现

  • 有深静脉血栓史者较无史者新发深静脉血栓风险更高(1.4% vs 0.8%,P=.03)。
  • 有史者近端血栓延伸风险更高(2.3% vs 1.6%,P=.045),出血风险更高(0.2% vs 0.04%,P=.03)。
  • EHIT II-IV、肺栓塞及血肿风险两组无显著差异(P=NS),两组均无治疗相关死亡。
  • 技术失败率两组相似(2.0% vs 1.2%,P=.07),但有史者远期再通风险增加(HR 1.90,95%CI 1.46-2.46,P<.001)。
  • 术后静脉临床严重程度评分及Heaviness、Aching、Swelling、Throbbing、Itching评分改善两组相当(P=NS)。

关键数值与推荐

  • 有深静脉血栓史者新发深静脉血栓1.4% vs 无史者0.8%(P=.03)。
  • 有史者近端血栓延伸2.3% vs 无史者1.6%(P=.045)。
  • 有史者出血0.2% vs 无史者0.04%(P=.03)。
  • 有史者再通风险HR 1.90(95%CI 1.46-2.46,P<.001)。

临床怎么用

  • 有深静脉血栓史患者行腔内热消融前应告知深静脉血栓风险虽低但仍升高。
  • 术前继续或停用抗凝应基于个案决策。
  • 有深静脉血栓史者术前继续抗凝未改变并发症风险,但整体出血风险增加(P=.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endovenous ablation is the standard of care for patients with symptomatic superficial venous insufficiency. For patients with a history of deep vein thrombosis (DVT), concern exists for an increased risk of postprocedural complications, particularly venous thromboembolism. The objective of this study was to evaluate the safety and efficacy of endovenous thermal ablation in patients with a history of DVT. METHODS: The national Vascular Quality Initiative Varicose Vein Registry was queried for superficial venous procedures performed from January 2014 to July 2021. Limbs treated with radiofrequency or laser ablation were compared between patients with and without a DVT history. The primary safety end point was incident DVT or endothermal heat-induced thrombosis (EHIT) II-IV in the treated limb at <3 months of follow-up. The secondary safety end points included any proximal thrombus extension (ie, EHIT I-IV), major bleeding, hematoma, pulmonary embolism, and death due to the procedure. The primary efficacy end point was technical failure (ie, recanalization at <1 week of follow-up). Secondary efficacy end points included the risk of recanalization over time and the postprocedural change in quality-of-life measures. Outcomes stratified by preoperative use of anticoagulation (AC) were also compared among those with prior DVT. RESULTS: Among 33,892 endovenous thermal ablations performed on 23,572 individual patients aged 13 to 90 years, 1698 patients (7.2%) had a history of DVT. Patients with prior DVT were older (P < .001), had a higher body mass index (P < .001), were more likely to be male at birth (P < .001) and Black/African American (P < .001), and had greater CEAP classifications (P < .001). A history of DVT conferred a higher risk of new DVT (1.4% vs 0.8%; P = .03), proximal thrombus extension (2.3% vs 1.6%; P = .045), and bleeding (0.2% vs 0.04%; P = .03). EHIT II-IV, pulmonary embolism, and hematoma risk did not differ by DVT history (P = NS). No deaths from treatment occurred in either group. Continuing preoperative AC in patients with prior DVT did not change the risk of any complications after endovenous ablation (P = NS) but did confer an increased hematoma risk among all endovenous thermal ablations and surgeries (P = .001). Technical failure was similar between groups (2.0% vs 1.2%; P = .07), although a history of DVT conferred an increased recanalization risk over time (hazard ratio, 1.90; 95% confidence interval, 1.46, 2.46; P < .001). The groups had comparable improvements in postprocedural venous clinical severity scores and Heaviness, Aching, Swelling, Throbbing, and Itching scores (P = NS). CONCLUSIONS: Endovenous thermal ablation for patients with a history of DVT was effective. However, appropriate patient counseling regarding a heightened DVT risk, albeit still low, is critical. The decision to continue or withhold AC preoperatively should be tailored on a case-by-case basis.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Chervonski E, Muqri F, Jacobowitz GR, et al. Safety and efficacy of endovenous ablation in patients with a history of deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38677553. doi:10.1016/j.jvsv.2024.101898

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。